| P50 | author | David R. Boulware | Q39519469 |
| P2093 | author name string | Jose E Vidal | |
| | Augusto C Penalva de Oliveira | |
| | Rafi F Dauar | |
| P2860 | cites work | Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study | Q21144623 |
| | Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings | Q24600270 |
| | Integrating cryptococcal antigen screening and pre-emptive treatment into routine HIV care | Q24610933 |
| | Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndrome | Q24630287 |
| | Profile of neurologic disorders associated with HIV/AIDS from Bangalore, south India (1989-96) | Q28143423 |
| | Mortality during the first year of potent antiretroviral therapy in HIV-1-infected patients in 7 sites throughout Latin America and the Caribbean | Q28749991 |
| | Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS | Q29617372 |
| | Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study | Q33272469 |
| | Cryptococcal neuroradiological lesions correlate with severity during cryptococcal meningoencephalitis in HIV-positive patients in the HAART era. | Q33328474 |
| | Major role for amphotericin B-flucytosine combination in severe cryptococcosis | Q33358131 |
| | The effect of HIV infection on adult meningitis in Indonesia: a prospective cohort study | Q33505477 |
| | Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases | Q33540873 |
| | Optimum timing of antiretroviral therapy for HIV-infected patients with concurrent serious opportunistic infections | Q33823233 |
| | High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out | Q33854516 |
| | Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa | Q33871884 |
| | Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy | Q33894498 |
| | Cross-sectional analysis of late HAART initiation in Latin America and the Caribbean: late testers and late presenters | Q33921227 |
| | Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review | Q33979497 |
| | Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature | Q33988155 |
| | Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. | Q34020746 |
| | Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients | Q34247688 |
| | Timing of initiation of antiretroviral drugs during tuberculosis therapy | Q34790184 |
| | Dose response effect of high-dose fluconazole for HIV-associated cryptococcal meningitis in southwestern Uganda | Q34874626 |
| | Cryptococcosis: a review of the Brazilian experience for the disease | Q35648585 |
| | Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options. | Q35799766 |
| | Role of quantitative CSF microscopy to predict culture status and outcome in HIV-associated cryptococcal meningitis in a Brazilian cohort | Q35957939 |
| | Thalidomide for steroid-dependent immune reconstitution inflammatory syndromes during AIDS | Q56839116 |
| | AIDS-associated cryptococcosis: a comparison of epidemiology, clinical features and outcome in the pre- and post-HAART eras. Experience of a single centre in Italy | Q58377850 |
| | Neurological disease in HIV-infected patients in the era of highly active antiretroviral treatment: a Brazilian experience | Q58855603 |
| | Fungal Burden, Early Fungicidal Activity, and Outcome in Cryptococcal Meningitis in Antiretroviral-Naive or Antiretroviral-Experienced Patients Treated with Amphotericin B or Fluconazole | Q59115058 |
| | The clinical spectrum of neurological manifestations in AIDS patients in Mexico | Q73163539 |
| | Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy | Q79331002 |
| | Epidemiology of HIV-associated cryptococcosis in France (1985-2001): comparison of the pre- and post-HAART eras | Q79946527 |
| | Guidelines for the diagnosis and management of neurological complications of HIV infection | Q80086394 |
| | Cryptococcus neoformans meningitis at 2 hospitals in Washington, D.C.: adherence of health care providers to published practice guidelines for the management of cryptococcal disease | Q81314782 |
| | Aids-related progressive multifocal leukoencephalopathy: a retrospective study in a referral center in São Paulo, Brazil | Q82051382 |
| | The burden of HIV-associated cryptococcal disease | Q83393819 |
| | Cryptococcemia. An analysis of 28 cases with emphasis on the clinical outcome and its etiologic agent | Q36040630 |
| | Brazilian policy of universal access to AIDS treatment: sustainability challenges and perspectives | Q36874607 |
| | Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy | Q36996124 |
| | The first ten years: achievements and challenges of the Brazilian program of universal access to HIV/AIDS comprehensive management and care, 1996-2006. | Q36997187 |
| | Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings | Q37168581 |
| | Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial | Q37189075 |
| | Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa | Q37347385 |
| | Mortality due to systemic mycoses as a primary cause of death or in association with AIDS in Brazil: a review from 1996 to 2006. | Q37528103 |
| | Strategies to optimize HIV treatment outcomes in resource-limited settings | Q37639163 |
| | Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis | Q37718319 |
| | Preventing deaths from cryptococcal meningitis: from bench to bedside | Q37929748 |
| | Excellent clinical outcomes and high retention in care among adults in a community-based HIV treatment program in rural Rwanda | Q37966781 |
| | Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa | Q38374183 |
| | Changing incidence of central nervous system diseases in the EuroSIDA cohort | Q38479888 |
| | Short course amphotericin B with high dose fluconazole for HIV-associated cryptococcal meningitis | Q38869006 |
| | Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort | Q38873960 |
| | Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial | Q38922578 |
| | Immune reconstitution inflammatory syndrome (IRIS) associated with Cryptococcus neoformans infection in AIDS patients | Q39288782 |
| | Cryptococcosis in AIDS patients: case study from 1996 to 2006 in Paroissien Hospital | Q40397308 |
| | Histopathological aspects of neurocryptococcosis in HIV-infected patients: autopsy report of 45 patients | Q42438313 |
| | Disseminated cryptococcosis in patients with AIDS. Clinical, microbiological, and immunological analysis of 51 patients | Q44204581 |
| | Introduction to late presentation for HIV treatment in Europe | Q44380930 |
| | Clinical and epidemiological features of 123 cases of cryptococcosis in Mato Grosso do Sul, Brazil | Q44939632 |
| | Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups | Q45068097 |
| | The decline of incident cases of HIV-associated neurological disorders in San Francisco, 1991-2003. | Q46005169 |
| | A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis. | Q46012365 |
| | Immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis: a prospective study | Q46051910 |
| | Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures | Q46091639 |
| | The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000. | Q46172301 |
| | Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis | Q46248271 |
| | Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries | Q46391119 |
| | Treatment of cryptococcal meningitis in Peruvian AIDS patients using amphotericin B and fluconazole | Q46426294 |
| | The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy | Q46433636 |
| | Temporary external lumbar drainage for reducing elevated intracranial pressure in HIV-infected patients with cryptococcal meningitis | Q47704442 |
| | [Temporal study in AIDS-associated disease in Brazil, 1980-1999]. | Q50662624 |
| | Clinical, epidemiological and outcome features of patients with cryptococcosis in Uberaba, Minas Gerais, Brazil. | Q50777922 |
| | Official information systems for cryptococcal meningitis, state of Rio de Janeiro, Southeastern Brazil. | Q51829829 |
| | [Cryptococosis: clinical epidemiological laboratorial study and fungi varieties in 96 patients]. | Q53765615 |
| | HIV-associated cryptococcal meningitis. | Q55046805 |
| | Antiretroviral therapy in resource-poor settings: scaling up inequalities? | Q56530779 |
| P433 | issue | 3 | |
| P921 | main subject | HIV/AIDS | Q12199 |
| | meningitis | Q48143 |
| | cryptococcal meningitis | Q18967011 |
| P304 | page(s) | 353-362 | |
| P577 | publication date | 2013-05-10 | |
| P1433 | published in | The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases | Q26853984 |
| P1476 | title | Strategies to reduce mortality and morbidity due to AIDS-related cryptococcal meningitis in Latin America | |
| P478 | volume | 17 | |